Cleared Traditional

K845022 - PATHO DX LATEX AGGLUTINATION STREP B KIT

K845022 is an FDA 510(k) clearance for PATHO DX LATEX AGGLUTINATION STREP B KIT, manufactured by Diagnostic Products Corp.. The device is a Class 1 Microbiology device with product code GTZ cleared through the Traditional 510(k) pathway after a 126-day FDA review.

K845022 · Diagnostic Products Corp. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1985
Decision
126d
Days
Class 1
Risk

K845022 is an FDA 510(k) clearance for the PATHO DX LATEX AGGLUTINATION STREP B KIT. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on May 2, 1985 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Diagnostic Products Corp. devices

FDA 510(k) Submission Details - K845022

510(k) Number K845022 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 27, 1984
Decision Date May 02, 1985
Days to Decision 126 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 102d · This submission: 126d
Pathway characteristics
Predicate-based equivalence.

GTZ Device Classification - Class 1, General Controls

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 89
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K845022.
QUIDEL QUEST STREP GROUP A TEST
K852806 · Quidel Corp. · Jul 1985
RAPID DIRECT STREP A LATEX AGGLUTINATION TEST
K852841 · Smithkline Diagnostics, Inc. · Jul 1985
BACTIGEN GROUP B STREPTOCOCCUS TEST
K850772 · Armkel, LLC · May 1985
CONFIRM IMMUNOASSAY FOR DETECTTION STREP-PYOGENES
K850256 · Abbott Laboratories · Apr 1985
STREP A QUICK
K850831 · Abbott Laboratories · Apr 1985
VENTRESCREEN STREP A TEST
K844855 · Ventrex Laboratories, Inc. · Jan 1985